XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.25.3

Medical Expenses Payable | 9 Months Ended
--- | ---
Sep. 30, 2025
Insurance [Abstract] |
Medical Expenses Payable | Medical Expenses Payable The following table is a detail of medical expenses payable as of September 30, 2025 and December 31, 2024:
| September 30, 2025 |  | December 31, 2024
Claims incurred but not paid | $ | 298,176 |  |  | $ | 168,357 |
Capitation and risk-sharing payable | 74,541 |  |  | 52,016 |
Other | 156,079 |  |  | 69,415 |
Medical expenses payable | $ | 528,796 |  |  | $ | 289,788 |
Each period, we re-examine previously established outstanding claims reserve estimates based on actual claims submissions and other changes in facts and circumstances. As more complete claim information becomes available, we adjust the amount of the estimates and include the changes in estimates in claim costs in the period in which the change is identified. Substantially, all of the total claims paid by us are known and settled within the first year from the date of service, and substantially, all remaining claim amounts are paid within a three-year period. The following table presents components of the change in medical expenses payable as of September 30, 2025 and 2024:
| September 30, 2025 |  | September 30, 2024
Claims incurred but not paid - beginning balance | $ | 168,357 |  |  | $ | 95,664 |
Incurred related to: |  |  |
Current year | 848,585 |  |  | 619,772 |
Prior years | (26,163) |  |  | (7,031) |
Total incurred, net of reinsurance | 822,422 |  |  | 612,741 |
Payments related to: |  |  |
Current year | 563,755 |  |  | 470,460 |
Prior years | 128,848 |  |  | 79,771 |
Total payments, net of reinsurance | 692,603 |  |  | 550,231 |
Claims incurred but not paid - ending balance | 298,176 |  |  | 158,174 |
Capitation payable, risk-sharing payable, and other | 230,620 |  |  | 138,951 |
Total medical expenses payable | $ | 528,796 |  |  | $ | 297,125 |
We re-examine previously established outstanding claims reserve estimates based on actual claims submissions and other changes in facts and circumstances. We recognized a favorable prior year development, excluding provision for adverse deviation, of $5,091 and $17,586 for the three and nine months ended September 30, 2025. The favorable prior year development was primarily due to better-than-expected claims recoveries and actual claims expense being less than expected.

X
- References No definition available. + Details
Name: | us-gaap_InsuranceAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/944/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 4D -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480081/944-40-50-4D + Details
Name: | us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration